Toll-like receptor 3 regulates Zika virus infection and associated host inflammatory response in primary human astrocytes.
Animals
Astrocytes
/ metabolism
Beclin-1
/ metabolism
Cell Death
/ physiology
Cell Line
Chlorocebus aethiops
Humans
Inflammation
/ metabolism
Intercellular Signaling Peptides and Proteins
/ metabolism
Neuroglia
/ metabolism
Signal Transduction
/ physiology
Toll-Like Receptor 3
/ metabolism
Transcription Factors
Vero Cells
Virus Replication
/ physiology
Zika Virus
/ pathogenicity
Zika Virus Infection
/ metabolism
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
08
2018
accepted:
19
11
2018
entrez:
9
2
2019
pubmed:
9
2
2019
medline:
30
10
2019
Statut:
epublish
Résumé
The connection between Zika virus (ZIKV) and neurodevelopmental defects is widely recognized, although the mechanisms underlying the infectivity and pathology in primary human glial cells are poorly understood. Here we show that three isolated strains of ZIKV, an African strain MR766 (Uganda) and two closely related Asian strains R103451 (Honduras) and PRVABC59 (Puerto Rico) productively infect primary human astrocytes, although Asian strains showed a higher infectivity rate and increased cell death when compared to the African strain. Inhibition of AXL receptor significantly attenuated viral entry of MR766 and PRVABC59 and to a lesser extend R103451, suggesting an important role of TAM receptors in ZIKV cell entry, irrespective of lineage. Infection by PRVABC59 elicited the highest release of inflammatory molecules, with a 8-fold increase in the release of RANTES, 10-fold increase in secretion of IP-10 secretion and a 12-fold increase in IFN-β secretion when compared to un-infected human astrocytes. Minor changes in the release of several growth factors, endoplasmic reticulum (ER)-stress response factors and the transcription factor, NF-κB were detected with the Asian strains, while significant increases in FOXO6, MAPK10 and JNK were detected with the African strain. Activation of the autophagy pathway was evident with increased expression of the autophagy related proteins Beclin1, LC3B and p62/SQSTM1 with all three strains of ZIKV. Pharmacological inhibition of the autophagy pathway and genetic inhibition of the Beclin1 showed minimal effects on ZIKV replication. The expression of toll-like receptor 3 (TLR3) was significantly increased with all three strains of ZIKV; pharmacological and genetic inhibition of TLR3 caused a decrease in viral titers and in viral-induced inflammatory response in infected astrocytes. We conclude that TLR3 plays a vital role in both ZIKV replication and viral-induced inflammatory responses, irrespective of the strains, while the autophagy protein Beclin1 influences host inflammatory responses.
Identifiants
pubmed: 30735502
doi: 10.1371/journal.pone.0208543
pii: PONE-D-18-23819
pmc: PMC6368285
doi:
Substances chimiques
Beclin-1
0
Intercellular Signaling Peptides and Proteins
0
TLR3 protein, human
0
Toll-Like Receptor 3
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0208543Subventions
Organisme : NIDA NIH HHS
ID : R01 DA036154
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Oncogene. 2001 Apr 19;20(17):2178-85
pubmed: 11360202
PLoS Pathog. 2006 Jun;2(6):e53
pubmed: 16789835
Crit Rev Immunol. 2006;26(2):149-88
pubmed: 16700651
Cell Stem Cell. 2016 Nov 3;19(5):663-671
pubmed: 27524440
J Virol. 2008 Nov;82(21):10349-58
pubmed: 18715906
J Neurosci. 2017 Feb 22;37(8):2161-2175
pubmed: 28123079
J Neuroimmune Pharmacol. 2017 Jun;12(2):219-232
pubmed: 28349242
PLoS Med. 2016 Oct 25;13(10):e1002157
pubmed: 27780196
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Front Cell Infect Microbiol. 2017 Jan 09;6:206
pubmed: 28119857
Am J Trop Med Hyg. 2018 Feb;98(2):432-444
pubmed: 29280428
Nat Med. 2004 Dec;10(12):1366-73
pubmed: 15558055
J Clin Invest. 2012 Apr;122(4):1368-76
pubmed: 22426207
J Neuroinflammation. 2015 Dec 30;12:244
pubmed: 26714634
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3516-21
pubmed: 14993594
Viruses. 2017 Jul 28;9(8):
pubmed: 28788100
Front Microbiol. 2015 Jul 06;6:653
pubmed: 26217309
Infect Genet Evol. 2017 Apr;49:134-137
pubmed: 28095299
Med Microbiol Immunol. 2016 Jun;205(3):269-73
pubmed: 26702627
BMC Neurosci. 2018 Feb 20;19(1):5
pubmed: 29463209
Front Microbiol. 2014 Aug 05;5:388
pubmed: 25140166
Adv Exp Med Biol. 2009;665:130-42
pubmed: 20429421
Biochim Biophys Acta. 2014 Oct;1843(10):2150-63
pubmed: 24440275
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
Virus Res. 2018 Aug 2;254:34-40
pubmed: 28899653
Cell Microbiol. 2009 Apr;11(4):604-15
pubmed: 19134117
Emerg Infect Dis. 2011 May;17(5):880-2
pubmed: 21529401
J Cell Biol. 1967 May;33(2):437-49
pubmed: 4292315
Emerg Microbes Infect. 2017 Mar 29;6(3):e16
pubmed: 28352123
N Engl J Med. 2016 Oct 20;375(16):1513-1523
pubmed: 27705091
J Virol. 2015 Jan 15;89(2):1024-35
pubmed: 25355898
Cell Discov. 2018 Apr 24;4:19
pubmed: 29707233
Cell Mol Biol Lett. 2016 Dec 13;21:29
pubmed: 28536631
FEBS Lett. 2001 Nov 16;508(2):259-64
pubmed: 11718727
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2636
pubmed: 24421913
Front Microbiol. 2014 Jun 03;5:266
pubmed: 24917859
J Virol. 2015 Sep;89(17):8880-96
pubmed: 26085147
Nat Microbiol. 2018 Mar;3(3):302-309
pubmed: 29379210
Glia. 2009 Sep;57(12):1251-64
pubmed: 19373940
Cells. 2013 Jan 25;2(1):83-104
pubmed: 24709646
Cell. 2010 Feb 5;140(3):313-26
pubmed: 20144757
Nat Rev Cancer. 2002 Apr;2(4):301-10
pubmed: 12001991
Acta Trop. 2015 Sep;149:138-47
pubmed: 25944351
Curr Protoc Microbiol. 2016 Nov 18;43:15D.4.1-15D.4.16
pubmed: 27858969
Cell Signal. 2018 Aug;48:64-68
pubmed: 29753850
J Virol. 2010 Jun;84(11):5627-36
pubmed: 20237085
Cell Stem Cell. 2016 Aug 4;19(2):258-265
pubmed: 27162029
Lipids Health Dis. 2012 Dec 18;11:173
pubmed: 23249523
Nat Immunol. 2009 Oct;10(10):1089-95
pubmed: 19734906
Mem Inst Oswaldo Cruz. 2018 May 14;113(6):e170542
pubmed: 29768624
Scientifica (Cairo). 2013;2013:580968
pubmed: 24455433
Front Neurosci. 2011 Mar 16;5:35
pubmed: 21441990
PLoS Pathog. 2017 Mar 9;13(3):e1006258
pubmed: 28278235
EMBO J. 2008 Apr 9;27(7):1110-21
pubmed: 18337753
J Biol Chem. 2008 Nov 28;283(48):33175-82
pubmed: 18772134
Cell Stem Cell. 2016 May 5;18(5):559-60
pubmed: 27152436
Nat Neurosci. 2018 Jan;21(1):63-71
pubmed: 29230053
Mol Biol Cell. 2015 Jun 15;26(12):2190-204
pubmed: 25904325
J Immunol. 1952 Aug;69(2):223-34
pubmed: 14946416
J Med Virol. 2016 Sep;88(9):1596-603
pubmed: 26895737
Lancet Infect Dis. 2016 Dec;16(12):1356-1363
pubmed: 27641777
Cell Rep. 2017 Jan 10;18(2):324-333
pubmed: 28076778
J Gen Virol. 2017 Aug;98(8):2061-2068
pubmed: 28786784
Development. 2016 Nov 15;143(22):4127-4136
pubmed: 27729407
mSphere. 2017 Jul 26;2(4):
pubmed: 28815211
J Virol. 2007 Oct;81(20):10933-49
pubmed: 17670819
J Virol. 2010 Oct;84(20):10438-47
pubmed: 20686019
EMBO J. 2001 Mar 15;20(6):1300-9
pubmed: 11250896
Nat Rev Immunol. 2002 Oct;2(10):725-34
pubmed: 12360211
Bull World Health Organ. 2017 Mar 01;95(3):191-198
pubmed: 28250532
EBioMedicine. 2016 Oct;12:161-169
pubmed: 27688094